John Lucas is a seasoned professional with extensive experience in analytical development and quality control within the biopharmaceutical industry. Currently serving as the Head of Analytical Development & Quality Control at Rhythm Pharmaceuticals Inc., John focuses on advancing therapeutics for rare genetic obesity disorders. Previous roles include Sr. Director of Analytical Chemistry at Amryt Pharma plc, and Aegerion Pharmaceuticals, where John specialized in method life cycle management and regulatory support. John has also held positions at Ironwood Pharmaceuticals, Altus Pharmaceuticals, Pfizer, and Novartis, contributing to analytical method development, process validation, and regulatory submissions. John holds a PhD in Biochemistry from The Julius Maximilians University of Würzburg and has a robust educational foundation in chemistry from prestigious institutions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices